When and How Long to Treat Chronic Lymphocytic Leukemia?Carsten Utoft Niemann, Barbara Eichhorst, Talha Munir et al.|American Society of Clinical Oncology Educational Book|2025Cited by 6
Acquired Bruton's tyrosine kinase mutations in patients treated on the ibrutinib and rituximab, ibrutinib alone, and ibrutinib and venetoclax arms of the national multi-centre Phase III FLAIR study in previously untreated CLL patientsCharlotte Evans, Talha Munir, Natasha Greatorex et al.|Blood|2025Cited by 2